These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 11872339

  • 1. Efficacy, tolerability and management of raltitrexed (Tomudex) monotherapy in patients with advanced colorectal cancer. a review of phase II/III trials.
    Cunningham D, Zalcberg J, Maroun J, James R, Clarke S, Maughan TS, Vincent M, Schulz J, González Barón M, Facchini T.
    Eur J Cancer; 2002 Mar; 38(4):478-86. PubMed ID: 11872339
    [Abstract] [Full Text] [Related]

  • 2. Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group.
    Sato A, Kurihara M, Horikoshi N, Aiba K, Kikkawa N, Shirouzu K, Mitachi Y, Sakata Y, Wakui A.
    Anticancer Drugs; 1999 Sep; 10(8):741-8. PubMed ID: 10573207
    [Abstract] [Full Text] [Related]

  • 3. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
    Cocconi G, Cunningham D, Van Cutsem E, Francois E, Gustavsson B, van Hazel G, Kerr D, Possinger K, Hietschold SM.
    J Clin Oncol; 1998 Sep; 16(9):2943-52. PubMed ID: 9738562
    [Abstract] [Full Text] [Related]

  • 4. Mature results from three large controlled studies with raltitrexed ('Tomudex').
    Cunningham D.
    Br J Cancer; 1998 Sep; 77 Suppl 2(Suppl 2):15-21. PubMed ID: 9579851
    [Abstract] [Full Text] [Related]

  • 5. Raltitrexed ('Tomudex') and radiotherapy can be combined as postoperative treatment for rectal cancer.
    Botwood N, James R, Vernon C, Price P.
    Ann Oncol; 2000 Aug; 11(8):1023-8. PubMed ID: 11038040
    [Abstract] [Full Text] [Related]

  • 6. Raltitrexed. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
    Gunasekara NS, Faulds D.
    Drugs; 1998 Mar; 55(3):423-35. PubMed ID: 9530547
    [Abstract] [Full Text] [Related]

  • 7. Overview of the tolerability of 'Tomudex' (raltitrexed): collective clinical experience in advanced colorectal cancer.
    Zalcberg J.
    Anticancer Drugs; 1997 Aug; 8 Suppl 2():S17-22. PubMed ID: 9376633
    [Abstract] [Full Text] [Related]

  • 8. Raltitrexed (Tomudex) in combination with 5-fluorouracil for the treatment of patients with advanced colorectal cancer: preliminary results from phase I clinical trials.
    Schwartz GK, Harstrick A, González Barón M.
    Eur J Cancer; 1999 Mar; 35 Suppl 1():S9-13. PubMed ID: 10645208
    [Abstract] [Full Text] [Related]

  • 9. Randomised trial comparing three different schedules of infusional 5FU and raltitrexed alone as first-line therapy in metastatic colorectal cancer. Final results of the Fédération Francophone de Cancérologie Digestive (FFCD) 9601 trial.
    Ducreux M, Bouche O, Pignon JP, Mousseau M, Raoul JL, Cassan P, Leduc B, Berger C, Dunant A, Fournet J, Bedenne L, FFCD 9601 Collaborative Group.
    Oncology; 2006 Mar; 70(3):222-30. PubMed ID: 16816536
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Combination of 5-Fluorouracil and folinic acid--is it still the standard therapy for advanced colorectal carcinoma?].
    Carnaghi C, Zucali P, Garassino I.
    Tumori; 2000 Mar; 86(5 Suppl 2):S19-25. PubMed ID: 11195298
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. First-line treatment with irinotecan and raltitrexed in metastatic colorectal cancer. Mature results of a multicenter phase II study.
    Aparicio J, Vicent JM, Maestu I, Bosch C, Galán A, Busquier I, Llorca C, Garcerá S, Campos JM, López-Tendero P, Balcells M.
    Oncology; 2005 Mar; 68(1):58-63. PubMed ID: 15809521
    [Abstract] [Full Text] [Related]

  • 15. 'Tomudex' (ZD1694): results of a randomised trial in advanced colorectal cancer demonstrate efficacy and reduced mucositis and leucopenia. The 'Tomudex' Colorectal Cancer Study Group.
    Cunningham D, Zalcberg JR, Rath U, Olver I, Van Cutsem E, Svensson C, Seitz JF, Harper P, Kerr D, Perez-Manga G.
    Eur J Cancer; 1995 Nov; 31A(12):1945-54. PubMed ID: 8562146
    [Abstract] [Full Text] [Related]

  • 16. Phase II trial of irinotecan and raltitrexed in chemotherapy-naive advanced colorectal cancer.
    Chiara S, Nobile MT, Tomasello L, Acquati M, Taveggia P, Murolo C, Percivale P, Rosso R.
    Anticancer Res; 2005 Nov; 25(2B):1391-6. PubMed ID: 15865096
    [Abstract] [Full Text] [Related]

  • 17. Clinical efficacy of 'Tomudex' (raltitrexed) in advanced colorectal cancer.
    Kerr DJ.
    Anticancer Drugs; 1997 Aug; 8 Suppl 2():S11-5. PubMed ID: 9376632
    [Abstract] [Full Text] [Related]

  • 18. Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial.
    Scheithauer W, Kornek GV, Ulrich-Pur H, Penz M, Raderer M, Salek T, Haider K, Kwasny W, Depisch D.
    Cancer; 2001 Apr 01; 91(7):1264-71. PubMed ID: 11283925
    [Abstract] [Full Text] [Related]

  • 19. Ralitrexed (Tomudex) or Nordic-FLv regimen in metastatic colorectal cancer: a randomized phase II study focusing on quality of life, patients' preferences and health economics.
    Norum J, Balteskard L, Edna TH, Laino R, Wählby L, Rønning G.
    J Chemother; 2002 Jun 01; 14(3):301-8. PubMed ID: 12120887
    [Abstract] [Full Text] [Related]

  • 20. Raltitrexed in the treatment of elderly patients with advanced colorectal cancer: an active and low toxicity regimen.
    Feliu J, Mel JR, Camps C, Escudero P, Aparicio J, Menéndez D, García Girón C, Rodriguez MR, Sánchez JJ, González Barón M, Oncopaz Cooperative Group Associated Hospitals.
    Eur J Cancer; 2002 Jun 01; 38(9):1204-11. PubMed ID: 12044507
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.